Information  X 
Enter a valid email address

PolareanImagPLCOrdGBP0.00037 (POLX)

Date Time Source Announcement
13 Nov 2018 7:00 am
RNS
Licencing Agreement with Duke University
06 Nov 2018 7:00 am
RNS
Company update
05 Nov 2018 7:00 am
RNS
Nominated Adviser Status
03 Oct 2018 7:00 am
RNS
Delivery of Xenon Polariser
23 Aug 2018 7:00 am
RNS
FIRST PATIENT IN PHASE III FDA CLINICAL TRIAL
22 Aug 2018 7:00 am
RNS
Half-year Report
27 Jul 2018 7:00 am
RNS
Company update
18 Jul 2018 2:28 pm
RNS
Result of AGM
17 Jul 2018 2:49 pm
RNS
Holding(s) in Company
10 Jul 2018 3:22 pm
RNS
Result of Placing
09 Jul 2018 2:41 pm
RNS
Proposed Placing to raise a minimum of �0.78m
21 Jun 2018 10:12 am
RNS
Holding(s) in Company
19 Jun 2018 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Investor Symposium
13 Jun 2018 7:00 am
RNS
Final Results
06 Jun 2018 7:00 am
RNS
Delivery of Xenon Polariser
31 May 2018 7:00 am
RNS
London Investor Symposium
22 May 2018 7:00 am
RNS
Delivery of Xenon Polariser
20 Apr 2018 7:00 am
RNS
Grant of Share Options
17 Apr 2018 7:00 am
RNS
Polarean technology used in severe asthma study
29 Mar 2018 7:00 am
RNS
AIM Admission & First Day of Dealings
  7:00 am
RNS
AIM Admission & First Day of Dealings
  7:00 am
RNS
Update on Polarean Imaging IPO
  7:00 am
RNS
Update on Polarean Imaging IPO
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t